Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy vs Radiotherapy + Temozolomide in Anaplastic Glioma (Phase 2)
KCT0000700Phase 2Recruiting
- Sponsor
- National Cancer Center Hospital
- Start
- Mar 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in anaplastic glioma, sponsored by National Cancer Center Hospital. Started Mar 2012; status: recruiting.
02
Drugs
temozolomide
03
Conditions
anaplastic glioma
Beyond the preview
Go deeper on KCT0000700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000700.